Differential analysis of serum and urine S100 proteins in juvenile-onset systemic lupus erythematosus (jSLE).


Journal

Clinical immunology (Orlando, Fla.)
ISSN: 1521-7035
Titre abrégé: Clin Immunol
Pays: United States
ID NLM: 100883537

Informations de publication

Date de publication:
05 2020
Historique:
received: 15 01 2020
revised: 28 02 2020
accepted: 28 02 2020
pubmed: 7 3 2020
medline: 24 10 2020
entrez: 6 3 2020
Statut: ppublish

Résumé

Up to 80% of juvenile-onset systemic lupus erythematosus (jSLE) patients develop lupus nephritis (LN) that affects treatment and prognosis. Easily accessible biomarkers do not exist to reliably diagnose LN, leaving kidney biopsies as the gold-standard. Calcium-binding S100 proteins are expressed by innate immune cells and epithelia and may act as biomarkers in systemic inflammatory conditions. We quantified S100 proteins in the serum and urine of jSLE patients, matched healthy and inflammatory (IgA vasculitis) controls. Serum S100A8/A9, and serum and urine S100A12 are increased in jSLE patients when compared to controls. Furthermore, serum S100A8/A9, and serum and urine S100A12 are increased in jSLE patients with active as compared to patients with inactive/no LN. No differences in S100A4 levels were seen between groups. This study demonstrates potential promise for S100A8/A9 and S100A12 as biomarkers for jSLE and active LN. Findings require to be confirmed and tested prospectively in independent and larger multi-ethnic cohorts.

Identifiants

pubmed: 32135275
pii: S1521-6616(20)30033-4
doi: 10.1016/j.clim.2020.108375
pii:
doi:

Substances chimiques

Biomarkers 0
Calgranulin A 0
Calgranulin B 0
S100A12 Protein 0
S100A12 protein, human 0
S100A8 protein, human 0
S100A9 protein, human 0
Creatinine AYI8EX34EU

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

108375

Subventions

Organisme : Medical Research Council
ID : MR/M01665X/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/M01665X/1
Pays : United Kingdom

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Auteurs

S J Donohue (SJ)

Department of Women's & Children's Health, Institute of Translational Medicine, University of Liverpool, Liverpool, UK.

A Midgley (A)

Department of Women's & Children's Health, Institute of Translational Medicine, University of Liverpool, Liverpool, UK.

J C Davies (JC)

Department of Women's & Children's Health, Institute of Translational Medicine, University of Liverpool, Liverpool, UK.

R D Wright (RD)

Department of Women's & Children's Health, Institute of Translational Medicine, University of Liverpool, Liverpool, UK.

I Bruce (I)

Centre for Musculoskeletal Research, Division of Musculoskeletal and Dermatological Sciences, School of Biological Sciences, University of Manchester, Manchester, UK; NIHR Manchester Biomedical Research Centre, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, The University of Manchester, Manchester, UK. Electronic address: ian.bruce@manchester.ac.uk.

M W Beresford (MW)

Department of Women's & Children's Health, Institute of Translational Medicine, University of Liverpool, Liverpool, UK; Department of Paediatric Rheumatology, Alder Hey Children's NHS Foundation Trust Hospital, Liverpool, UK; National Institute for Health Research (NIHR) Alder Hey Clinical Research Facility, Alder Hey Children's NHS Foundation Trust Hospital, UK.

C M Hedrich (CM)

Department of Women's & Children's Health, Institute of Translational Medicine, University of Liverpool, Liverpool, UK; Department of Paediatric Rheumatology, Alder Hey Children's NHS Foundation Trust Hospital, Liverpool, UK; National Institute for Health Research (NIHR) Alder Hey Clinical Research Facility, Alder Hey Children's NHS Foundation Trust Hospital, UK. Electronic address: christian.hedrich@liverpool.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH